Proteome Sciences (LON:PRM) Stock Price Up 9% – Still a Buy?

Proteome Sciences plc (LON:PRM)’s stock price traded up 9% during trading on Monday . The stock traded as high as GBX 3.91 ($0.05) and last traded at GBX 3.35 ($0.04). 967,070 shares were traded during mid-day trading, an increase of 496% from the average session volume of 162,146 shares. The stock had previously closed at GBX 3.07 ($0.04).

Proteome Sciences Stock Performance

The stock has a market cap of £9.89 million, a PE ratio of -335.00 and a beta of 0.07. The business has a 50 day moving average price of GBX 2.72 and a two-hundred day moving average price of GBX 3.15.

Proteome Sciences Company Profile

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.